Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fumaderm with or without 311 nm UVB in adults with psoriasis vulgaris
2006-000501-37Phase 4Active
- Sponsor
- Medizinische Fakultät der TU Dresden
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fumaderm in plaque psoriasis (2 arms), sponsored by Medizinische Fakultät der TU Dresden. Primary endpoint: PASI 75 response difference between body halves. Started Aug 2006; status: active.
02
Drugs
Fumaderm
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2006-000501-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000501-37.